PL409386A1 - Peptide preparations to be used as a pharmaceutical or food additive in prevention and treatment of neurodegenerative diseases - Google Patents

Peptide preparations to be used as a pharmaceutical or food additive in prevention and treatment of neurodegenerative diseases

Info

Publication number
PL409386A1
PL409386A1 PL409386A PL40938614A PL409386A1 PL 409386 A1 PL409386 A1 PL 409386A1 PL 409386 A PL409386 A PL 409386A PL 40938614 A PL40938614 A PL 40938614A PL 409386 A1 PL409386 A1 PL 409386A1
Authority
PL
Poland
Prior art keywords
prevention
treatment
neurodegenerative diseases
pharmaceutical
food additive
Prior art date
Application number
PL409386A
Other languages
Polish (pl)
Inventor
Andrzej W. Lipkowski
Mariusz Sacharczuk
Aleksandra Misicka-Kęsik
Krzysztof Różycki
Original Assignee
Instytut Medycyny Doświadczalnej I Klinicznej Im. Mirosława Mossakowskiego Polskiej Akademii Nauk
Instytut Homeostazy Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Medycyny Doświadczalnej I Klinicznej Im. Mirosława Mossakowskiego Polskiej Akademii Nauk, Instytut Homeostazy Spółka Z Ograniczoną Odpowiedzialnością filed Critical Instytut Medycyny Doświadczalnej I Klinicznej Im. Mirosława Mossakowskiego Polskiej Akademii Nauk
Priority to PL409386A priority Critical patent/PL409386A1/en
Publication of PL409386A1 publication Critical patent/PL409386A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Przedmiotem wynalazku jest preparat peptydowy do zastosowania w leczeniu lub profilaktyce chorób neurodegeneracyjnych, przy czym leczenie lub profilaktyka wymienionych chorób związana jest z hamowaniem agregacji białek układu nerwowego, w tym ß-amyloidu, do zastosowania w leczeniu lub profilaktyce choroby Alzheimera lub choroby Parkinsona.The present invention relates to a peptide preparation for use in the treatment or prevention of neurodegenerative diseases, wherein the treatment or prevention of said diseases is associated with inhibition of aggregation of nervous system proteins, including β-amyloid, for use in the treatment or prevention of Alzheimer's disease or Parkinson's disease.

PL409386A 2014-09-06 2014-09-06 Peptide preparations to be used as a pharmaceutical or food additive in prevention and treatment of neurodegenerative diseases PL409386A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL409386A PL409386A1 (en) 2014-09-06 2014-09-06 Peptide preparations to be used as a pharmaceutical or food additive in prevention and treatment of neurodegenerative diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL409386A PL409386A1 (en) 2014-09-06 2014-09-06 Peptide preparations to be used as a pharmaceutical or food additive in prevention and treatment of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
PL409386A1 true PL409386A1 (en) 2016-03-14

Family

ID=55450797

Family Applications (1)

Application Number Title Priority Date Filing Date
PL409386A PL409386A1 (en) 2014-09-06 2014-09-06 Peptide preparations to be used as a pharmaceutical or food additive in prevention and treatment of neurodegenerative diseases

Country Status (1)

Country Link
PL (1) PL409386A1 (en)

Similar Documents

Publication Publication Date Title
PH12019501414A1 (en) Amino acid compositions and methods for the treatment of liver diseases
PH12019501339A1 (en) Amino acid compositions and methods for the treatment of muscle diseases and disorders
HUE059050T2 (en) Preparations containing amino acids for use in the treatment of diseases associated with mitochondrial disorders
MX2019007480A (en) Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation.
EA201691582A1 (en) NEW PHARMACEUTICAL PREPARATIONS
EP3261721A4 (en) Use of pridopidine to improve cognitive function and for treating alzheimer's disease
EA201690159A1 (en) METHODS AND COMPOSITIONS FOR CANCER TREATMENT
EA201692109A1 (en) OPTIONS OF ANTIBODIES TO FACTOR D AND THEIR APPLICATION
PH12017500032B1 (en) Improved a㟠protofibril binding antibodies
BR112015022041A2 (en) Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders
EP3290514A4 (en) Application of pi4kiii protein and related membrane protein complex in treating alzheimer's disease
MX2019003805A (en) Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies.
MX2019001634A (en) AMIDAS COMPOUNDS, PHARMACEUTICAL COMPOSITIONS OF THESE AND METHODS TO USE THEM.
LT3586837T (en) COMPOSITIONS INCLUDING AMINO ACIDS FOR USE IN THE PREVENTION AND TREATMENT OF LIVER DISEASES
MX2015000618A (en) Di-and tri-heteroaryl derivatives as inhibitors of protein aggregation.
SG10201805646WA (en) Angiopoietin-like 4 antibodies and methods of use
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
ZA201702085B (en) Preparation of soy protein products ("s810")
IL265911A (en) Apilimod compositions and methods for using same in the treatment of alzheimer's disease
SI3413870T1 (en) Igmezin for use in the treatment of Alzheimer's disease
PH12017501694B1 (en) Compositions for the treatment of fibrosis and fibrosis-related diseases
MD20180049A2 (en) Pharmaceutical composition
EA201790020A1 (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
MX2019008603A (en) A pharmaceutical composition comprising an oxazine derivative and its use in the treatment or prevention of alzheimer's disease.
SMT202100070T1 (en) Complex and compositions for the treatment of ophthalmic and dermatological diseases